{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:08:15Z","timestamp":1791083295364,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Use of rifampin is required for short-course treatment regimens for tuberculosis. Tuberculosis caused by isolates of M. tuberculosis with resistance to rifampin and susceptibility to isoniazid is unusual, but it has been recognized through surveillance. Patients with tuberculosis (cases) with rifampin mono-resistance were compared with HIV-matched controls with tuberculosis caused by a drug-susceptible isolate. A total of 77 cases of rifampin mono-resistant tuberculosis were identified in this multicenter study. Three were determined to be laboratory contaminants, and 10 cases had an epidemiologic link to a case with rifampin mono-resistant tuberculosis, suggesting primary acquisition of rifampin-resistant isolates. Of the remaining 64 cases and 126 controls, there was no difference between cases and controls with regard to age, sex, race, foreign birth, homelessness, or history of incarceration. Cases were more likely to have a history of prior tuberculosis than were controls. Of the 38 cases and 74 controls with HIV infection, there was no difference between cases and controls with regard to age, sex, race, foreign birth, homelessness, history of incarceration, or prior tuberculosis. Cases were more likely to have histories of diarrhea, rifabutin use, or antifungal therapy. Laboratory analysis of available isolates showed that there was no evidence of spread of a single clone of M. tuberculosis. Further studies are needed to identify the causes of the development of rifampin resistance in HIV-infected persons with tuberculosis and to develop strategies to prevent its emergence.<\/jats:p>","DOI":"10.1164\/ajrccm.157.6.9712009","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:39:58Z","timestamp":1365082798000},"page":"1881-1884","source":"Crossref","is-referenced-by-count":69,"title":["Risk Factors for Rifampin Mono-resistant Tuberculosis"],"prefix":"10.1093","volume":"157","author":[{"given":"REN\u00c9E","family":"RIDZON","sequence":"first","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CYNTHIA G.","family":"WHITNEY","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MATTHEW T.","family":"McKENNA","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JEFFERY P.","family":"TAYLOR","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUSAN H.","family":"ASHKAR","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANNETTE T.","family":"NITTA","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SYDNEY M.","family":"HARVEY","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SARAH","family":"VALWAY","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHARLES","family":"WOODLEY","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT","family":"COOKSEY","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IDA M.","family":"ONORATO","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Epidemiology Program Office, and Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia; Infectious Disease Epidemiology and Surveillance Division, Texas Department of Health, Austin, Texas; Tuberculosis Control Program, Los Angeles County Department of Health Services, Los Angeles County Public Health Laboratory, Los Angeles, Calfornia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1998,6,1]]},"reference":[{"key":"2026032709175724300_B1","first-page":"423","article-title":"Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.","volume":"133","author":"Mitchison","year":"1986","journal-title":"Am. Rev. Respir. Dis"},{"key":"2026032709175724300_B2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1164\/ajrccm.149.5.8173779","article-title":"Treatment of tuberculosis and tuberculosis infection in adults and children.","volume":"149","author":"American Thoracic Society","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2026032709175724300_B3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1994.03510330043032","article-title":"Nationwide survey of drug-resistant tuberculosis in the United States.","volume":"271","author":"Bloch","year":"1994","journal-title":"J.A.M.A"},{"key":"2026032709175724300_B4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0962-8479(95)90522-7","article-title":"Drug resistant tuberculosis in sub-Saharan Africa: an estimation of incidence and cost for the year 2000.","volume":"76","author":"Carpels","year":"1995","journal-title":"Tubercle"},{"key":"2026032709175724300_B5","first-page":"609","article-title":"Anti-tuberculosis initial drug resistance of Mycobacterium tuberculosis in Kenya: a ten-year review.","volume":"70","author":"Githui","year":"1993","journal-title":"East Afr. Med. J."},{"key":"2026032709175724300_B6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.bi.65.070196.001243","article-title":"Molecular mechanisms of drug resistance in Mycobacterium tuberculosis.","volume":"65","author":"Blanchard","year":"1996","journal-title":"Annu. Rev. Biochem"},{"key":"2026032709175724300_B7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights.","volume":"8","author":"Musser","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"2026032709175724300_B8","first-page":"A144","article-title":"Epidemiology and diagnosis of tuberculosis (abstract).","volume":"151(Suppl.)","author":"Burwen","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2026032709175724300_B9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(95)91074-3","article-title":"Rifampin-resistant Mycobacterium tuberculosis.","volume":"345","author":"Weltman","year":"1995","journal-title":"Lancet"},{"key":"2026032709175724300_B10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1164\/ajrccm.152.3.7663785","article-title":"Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.","volume":"152","author":"Nolan","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2026032709175724300_B11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM199606133342404","article-title":"Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis.","volume":"334","author":"Bishai","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(96)03027-9","article-title":"The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco.","volume":"348","author":"Bradford","year":"1996","journal-title":"Lancet"},{"key":"2026032709175724300_B13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/jcm.31.2.406-409.1993","article-title":"Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.","volume":"31","author":"van Embden","year":"1993","journal-title":"J. Clin. Microbiol"},{"key":"2026032709175724300_B14"},{"key":"2026032709175724300_B15"},{"key":"2026032709175724300_B16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/jcm.32.4.1095-1098.1994","article-title":"Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase B subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.","volume":"32","author":"Kapur","year":"1994","journal-title":"J. Clin. Microbiol"},{"key":"2026032709175724300_B17"},{"key":"2026032709175724300_B18"},{"key":"2026032709175724300_B19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0962-8479(92)90065-R","article-title":"High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia.","volume":"73","author":"Jarallah","year":"1994","journal-title":"Tubercle"},{"key":"2026032709175724300_B20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1164\/ajrccm.153.2.8564140","article-title":"Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS.","volume":"153","author":"Lutfey","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2026032709175724300_B21"},{"key":"2026032709175724300_B22","first-page":"437","article-title":"Rifabutin prophylaxis against Mycobacterium avium complex infection.","volume":"330","author":"Reichman","year":"1994","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B23","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJM199212173272514","article-title":"Malabsorption of antituberculosis medication by a patient with AIDS.","volume":"327","author":"Berning","year":"1992","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1056\/NEJM199502023320518","article-title":"Drug malabsorption and resistant tuberculosis in HIV-infected patients.","volume":"332","author":"Patel","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B25","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/infdis\/168.6.1559","article-title":"Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.","volume":"168","author":"Gordon","year":"1993","journal-title":"J. Infect. Dis."},{"key":"2026032709175724300_B26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-127-4-199708150-00006","article-title":"Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.","volume":"127","author":"Sahai","year":"1997","journal-title":"Ann. Intern. Med"},{"key":"2026032709175724300_B27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/106002809603000901","article-title":"Low antituberculosis drug concentrations in patients with AIDS.","volume":"30","author":"Peloquin","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"2026032709175724300_B28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-124-6-199603150-00006","article-title":"Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.","volume":"124","author":"Trapnell","year":"1996","journal-title":"Ann. Intern. Med"},{"key":"2026032709175724300_B29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199405053301817","article-title":"Fluconazole and enhanced effect of rifabutin prophylaxis.","volume":"330","author":"Narang","year":"1994","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.","volume":"230","author":"Selwyn","year":"1989","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B31"},{"key":"2026032709175724300_B32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199608083350603","article-title":"A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.","volume":"335","author":"Pierce","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"2026032709175724300_B33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM199608083350604","article-title":"Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both.","volume":"335","author":"Havlir","year":"1996","journal-title":"N. Engl. J. Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/157\/6\/1881\/67447954\/ajrccm_157_6_1881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/157\/6\/1881\/67447954\/ajrccm_157_6_1881.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:18:07Z","timestamp":1774617487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/157\/6\/1881\/8531319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6,1]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1998,6,1]]},"published-print":{"date-parts":[[1998,6,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.157.6.9712009","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,6]]},"published":{"date-parts":[[1998,6,1]]}}}